Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Guillain-Barre Syndrome | 4 | 2021 | 1495 | 1.35 | Why? |
| Hashimoto Disease | 2 | 2019 | 74 | 0.86 | Why? |
| Polyneuropathies | 1 | 2021 | 157 | 0.76 | Why? |
| Infectious Encephalitis | 1 | 2018 | 20 | 0.74 | Why? |
| Moyamoya Disease | 1 | 2017 | 17 | 0.70 | Why? |
| Vertebral Artery | 1 | 2017 | 52 | 0.68 | Why? |
| Status Epilepticus | 1 | 2021 | 303 | 0.67 | Why? |
| Muscular Diseases | 1 | 2021 | 392 | 0.59 | Why? |
| Carotid Artery Diseases | 1 | 2017 | 251 | 0.54 | Why? |
| Encephalitis | 2 | 2019 | 797 | 0.53 | Why? |
| Seizures | 4 | 2021 | 1163 | 0.41 | Why? |
| Anticonvulsants | 3 | 2019 | 634 | 0.37 | Why? |
| Euthanasia, Active | 2 | 2004 | 3 | 0.35 | Why? |
| Evoked Potentials, Motor | 1 | 2004 | 54 | 0.28 | Why? |
| Restless Legs Syndrome | 1 | 2004 | 53 | 0.27 | Why? |
| Motor Cortex | 1 | 2004 | 71 | 0.27 | Why? |
| Persistent Vegetative State | 1 | 2004 | 34 | 0.26 | Why? |
| Catholicism | 1 | 2004 | 64 | 0.26 | Why? |
| Spinal Cord Ischemia | 1 | 2021 | 30 | 0.23 | Why? |
| Isaacs Syndrome | 1 | 2018 | 1 | 0.19 | Why? |
| Nutritional Support | 1 | 2004 | 447 | 0.19 | Why? |
| Stroke | 5 | 2020 | 8839 | 0.19 | Why? |
| Leukoencephalopathies | 2 | 2019 | 230 | 0.19 | Why? |
| Central Nervous System Bacterial Infections | 1 | 2017 | 5 | 0.18 | Why? |
| Cerebral Angiography | 2 | 2017 | 391 | 0.18 | Why? |
| Autoantigens | 1 | 2020 | 388 | 0.17 | Why? |
| Myelitis, Transverse | 1 | 2021 | 218 | 0.17 | Why? |
| Whipple Disease | 1 | 2017 | 38 | 0.17 | Why? |
| Diplopia | 1 | 2018 | 84 | 0.17 | Why? |
| Withholding Treatment | 1 | 2004 | 798 | 0.17 | Why? |
| Muscle Weakness | 1 | 2021 | 406 | 0.17 | Why? |
| Epilepsies, Partial | 1 | 2017 | 44 | 0.17 | Why? |
| Headache | 2 | 2019 | 2257 | 0.17 | Why? |
| tau Proteins | 1 | 2017 | 162 | 0.16 | Why? |
| Narcolepsy | 1 | 2017 | 80 | 0.16 | Why? |
| Acetamides | 1 | 2017 | 141 | 0.15 | Why? |
| Tacrolimus | 1 | 2019 | 435 | 0.15 | Why? |
| Amyloid beta-Peptides | 1 | 2017 | 185 | 0.15 | Why? |
| HLA Antigens | 1 | 2020 | 830 | 0.14 | Why? |
| Drugs, Investigational | 1 | 2017 | 198 | 0.14 | Why? |
| Pyridones | 1 | 2018 | 738 | 0.12 | Why? |
| Autoantibodies | 2 | 2020 | 2094 | 0.12 | Why? |
| Brain Ischemia | 2 | 2018 | 2813 | 0.12 | Why? |
| Epilepsy | 2 | 2019 | 1401 | 0.10 | Why? |
| Genotype | 1 | 2020 | 4697 | 0.09 | Why? |
| Humans | 27 | 2021 | 930598 | 0.09 | Why? |
| Alzheimer Disease | 1 | 2017 | 1020 | 0.08 | Why? |
| Endovascular Procedures | 1 | 2017 | 1302 | 0.08 | Why? |
| Cytokines | 2 | 2020 | 15010 | 0.08 | Why? |
| Peptide Fragments | 1 | 2017 | 2075 | 0.08 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.07 | Why? |
| Drug Design | 1 | 2017 | 2627 | 0.07 | Why? |
| Physical Stimulation | 1 | 2004 | 42 | 0.07 | Why? |
| Reaction Time | 1 | 2004 | 96 | 0.07 | Why? |
| Magnetics | 1 | 2004 | 66 | 0.07 | Why? |
| Dementia | 1 | 2017 | 1861 | 0.07 | Why? |
| Psychomotor Performance | 1 | 2004 | 110 | 0.07 | Why? |
| Europe | 1 | 2020 | 12702 | 0.06 | Why? |
| Ethics, Clinical | 1 | 2004 | 93 | 0.06 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Fingers | 1 | 2004 | 221 | 0.06 | Why? |
| Immunosuppressive Agents | 1 | 2019 | 6331 | 0.05 | Why? |
| Attitude to Death | 1 | 2004 | 307 | 0.05 | Why? |
| Spinal Cord | 1 | 2021 | 281 | 0.05 | Why? |
| Bioethics | 1 | 2004 | 253 | 0.05 | Why? |
| Fluid Therapy | 1 | 2004 | 628 | 0.05 | Why? |
| Histamine H3 Antagonists | 1 | 2017 | 1 | 0.05 | Why? |
| Organizational Policy | 1 | 2004 | 694 | 0.05 | Why? |
| Orexins | 1 | 2017 | 21 | 0.04 | Why? |
| Tropheryma | 1 | 2017 | 28 | 0.04 | Why? |
| Tomography Scanners, X-Ray Computed | 1 | 2018 | 98 | 0.04 | Why? |
| Intracranial Arteriovenous Malformations | 1 | 2017 | 71 | 0.04 | Why? |
| Disorders of Excessive Somnolence | 1 | 2017 | 39 | 0.04 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2020 | 88759 | 0.04 | Why? |
| Diagnostic Techniques, Ophthalmological | 1 | 2018 | 136 | 0.04 | Why? |
| Half-Life | 1 | 2017 | 298 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Child | 2 | 2018 | 70012 | 0.04 | Why? |
| Biological Availability | 1 | 2017 | 388 | 0.04 | Why? |
| Aged | 7 | 2020 | 215776 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Neurologic Examination | 1 | 2018 | 428 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.04 | Why? |
| Male | 6 | 2020 | 367725 | 0.04 | Why? |
| Statistics as Topic | 1 | 2017 | 370 | 0.03 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.03 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.03 | Why? |
| Nitriles | 1 | 2018 | 1053 | 0.03 | Why? |
| Austria | 1 | 2018 | 1259 | 0.03 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2017 | 604 | 0.03 | Why? |
| Ischemia | 1 | 2021 | 901 | 0.03 | Why? |
| Intracranial Aneurysm | 1 | 2017 | 504 | 0.03 | Why? |
| Magnetic Resonance Imaging | 2 | 2018 | 6551 | 0.03 | Why? |
| Internationality | 1 | 2004 | 3297 | 0.03 | Why? |
| Independent Living | 1 | 2017 | 842 | 0.03 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2017 | 2324 | 0.03 | Why? |
| Stents | 1 | 2017 | 916 | 0.02 | Why? |
| Decision Making | 1 | 2004 | 3132 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Societies, Medical | 1 | 2004 | 6907 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Case-Control Studies | 1 | 2004 | 17671 | 0.02 | Why? |
| Quality of Life | 1 | 2004 | 9820 | 0.02 | Why? |
| Germany | 1 | 2018 | 9196 | 0.01 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.01 | Why? |
| Animals | 2 | 2018 | 78931 | 0.01 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
| Italy | 1 | 2018 | 38444 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
Gigli's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(117)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_